Cited by 72

The DOI matches its Crossref record.

Cholesterol starvation decreases P34 cdc2 kinase activity and arrests the cell cycle at G2

Martínez‐Botas, Javier, Suárez, Yajaira, Ferruelo, Antonio J., Gómez‐Coronado, Diego, Lasunció, Miguel A·1999·The FASEB Journal

Abstract

As a major component of mammalian cell plasma membranes, cholesterol is essential for cell growth. Accordingly, the restriction of cholesterol provision has been shown to result in cell proliferation inhibition. We explored the potential regulatory role of cholesterol on cell cycle progression. MOLT‐4 and HL‐60 cell lines were cultured in a cholesterol‐deficient medium and simultaneously exposed to SKF 104976, which is a specific inhibitor of lanosterol 14‐α demethylase. Through HPLC analyses with on‐line radioactivity detection, we found that SKF 104976 efficiently blocked the [ 14 C]‐acetate incorporation into cholesterol, resulting in an accumulation of lanosterol and dihydrolanosterol, without affecting the synthesis of mevalonic acid. The inhibitor also produced a rapid and intense inhibition of cell proliferation (IC 50 = 0.1 µM), as assessed by both [ 3 H]‐thymidine incorporation into DNA and cell counting. Flow cytometry and morphological examination showed that treatment with SKF 104976 for 48 h or longer resulted in the accumulation of cells specifically at G2 phase, whereas both the G1 traversal and the transition through S were unaffected. The G2 arrest was accompanied by an increase in the hyperphosphorylated form of p34 cdc2 and a reduction of its activity, as determined by assaying the H1 histone phosphorylating activity of p34 cdc2 immunoprecipitates. The persistent deficiency of cholesterol induced apoptosis. However, supplementing the medium with cholesterol, either in the form of LDL or free cholesterol dissolved in ethanol, completely abolished these effects, whereas mevalonate was ineffective. Caffeine, which abrogates the G2 checkpoint by preventing p34 cdc2 phosphorylation, reduced the accumulation in G2 when added to cultures containing cells on transit to G2, but was ineffective in cells arrested at G2 by sustained cholesterol starvation. Cells arrested in G2, however, were still viable and responded to cholesterol provision by activating p34 cdc2 and resuming the cell cycle. We conclude that in both lymphoblastoid and promyelocytic cells, cholesterol availability governs the G2 traversal, probably by affecting p34 cdc2 activity.—Martínez‐Botas, J., Suárez, Y., Ferruelo, A. J., Gómez‐Coronado, D., Lasunción, M.A. Cholesterol starvation decreases P34 cdc2 kinase activity and arrests the cell cycle at G2. FASEB J. 13, 1359–1370 (1999)

Overview

Integrity signals

Registry

Crossref · 10.1096/fasebj.13.11.1359

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 62

  1. 10.1016/S0092-8674(85)80116-1 · DOI
  2. Smith J. R., 1988, Multiple sterol regulatory elements in promoter for hamster 3‐hydroxy‐3‐methyglutaryl‐coenzyme A synthase, J. Biol. Chem., 263, 18480, 10.1016/S0021-9258(19)81383-2 · DOI
  3. 10.1073/pnas.93.2.945 · DOI
  4. Spear D. H., 1992, Molecular cloning and promoter analysis of the rat liver farnesyl diphosphate synthase gene, J. Biol. Chem., 267, 14462, 10.1016/S0021-9258(19)49735-4 · DOI
  5. 10.1074/jbc.270.37.21958 · DOI
  6. 10.1073/pnas.80.24.7501 · DOI
  7. 10.1074/jbc.270.43.25812 · DOI
  8. 10.1016/S0092-8674(00)80213-5 · DOI · Paper page
  9. 10.1038/251419a0 · DOI
  10. Brown M. S., 1974, Suppression of 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7‐ketocholesterol, J. Biol. Chem., 249, 7306, 10.1016/S0021-9258(19)42106-6 · DOI · Paper page
  11. 10.1073/pnas.72.5.1950 · DOI
  12. 10.1073/pnas.76.10.5056 · DOI
  13. 10.1182/blood.V84.8.2689.2689 · DOI
  14. 10.1016/S0021-9258(18)98884-8 · DOI
  15. 10.1073/pnas.88.9.3628 · DOI
  16. Keyomarsi K., 1991, Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin, Cancer Res., 51, 3602
  17. 10.1016/0021-9150(93)90107-6 · DOI
  18. 10.1016/S0021-9258(18)92913-3 · DOI
  19. 10.1002/eji.1830240204 · DOI
  20. Raiteri M., 1997, Pharmacological control of the mevalonate pathway: effect on arterial smooth muscle cell proliferation, J. Pharmacol. Exp. Ther., 281, 1144, 10.1016/S0022-3565(24)36722-9 · DOI
  21. 10.1006/excr.1997.3480 · DOI
  22. Vogt A., 1996, Protein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts, Oncogene, 13, 1991
  23. 10.1002/jcp.1041490215 · DOI
  24. 10.1002/jcp.1041550312 · DOI
  25. Forgue‐Lafitte M. E., 1992, Effects of ketoconazole on the proliferation and cell cycle of human cancer cell lines, Cancer Res., 52, 6827
  26. Cuthbert J. A., 1990, Inhibition by 6‐fluoro‐mevalonate demonstrates that mevalonate or one of the meva‐lonate phosphates is necessary for lymphocyte proliferation, J. Biol. Chem., 265, 18568, 10.1016/S0021-9258(17)44789-2 · DOI
  27. 10.1111/j.1440-1681.1993.tb01733.x · DOI
  28. 10.1016/0167-4889(89)90202-4 · DOI
  29. Graña X., 1995, Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin‐dependent kinase inhibitors (CKIs), Oncogene, 11, 211
  30. 10.1126/science.274.5293.1672 · DOI · Paper page
  31. 10.1016/0955-0674(94)90058-2 · DOI
  32. 10.1016/S0955-0674(96)80080-9 · DOI
  33. 10.1126/science.274.5293.1652 · DOI · Paper page
  34. 10.1091/mbc.6.9.1197 · DOI
  35. Gray‐Bablin J., 1997, Lovastatin induction of cyclin‐dependent kinase inhibitors in human breast cells occurs in a cell cycle‐independent fashion, Cancer Res., 57, 604
  36. 10.1016/S0022-1759(97)00007-0 · DOI
  37. Chung B. H., 1986, Methods in Enzymology, 181
  38. 10.1016/S0021-9258(18)64849-5 · DOI · Paper page
  39. Palacín M., 1988, Utilization of glucose, alanine, lactate, and glycerol as lipogenic substrates by periuterine adipose tissue in situ in fed and starved rats, J. Lipid Res., 29, 26, 10.1016/S0022-2275(20)38564-3 · DOI
  40. 10.1016/S0006-2952(97)00635-7 · DOI
  41. 10.1016/0003-2697(76)90527-3 · DOI · Paper page
  42. Mayer R. J., 1991, Effects of a novel lanosterol 14 alpha‐demethylase inhibitor on the regulation of 3‐hydroxy‐3‐methyglutaryl‐coenzyme A reductase in Hep G2 cells, J. Biol. Chem., 266, 20070, 10.1016/S0021-9258(18)54892-4 · DOI
  43. Demarcq C., 1994, The role of cell cycle progression in cisplatin‐induced apoptosis in Chinese hamster ovary cells, Cell Growth Differ., 5, 983
  44. 10.1016/0092-8674(88)90175-4 · DOI
  45. 10.1038/336738a0 · DOI
  46. 10.1016/0092-8674(92)90153-4 · DOI
  47. 10.1038/nm1096-1140 · DOI
  48. Hain J., 1993, Caffeine release of radiation induced S and G2 phase arrest in V79 hamster cells: increase of histone messenger RNA levels and p34cdc2 activation, Cancer Res., 53, 1507
  49. Lock R. B., 1994, Concentration‐dependent differences in the mechanisms by which caffeine potentiates etoposide cytotoxicity in HeLa cells, Cancer Res., 54, 4933
  50. Chen H. W., 1988, A mammalian mutant cell lacking detectable lanosterol 14 alpha‐methyl demethylase activity, J. Biol. Chem., 263, 1248, 10.1016/S0021-9258(19)57293-3 · DOI
  51. Haeffner E. W., 1984, Cholesterol‐induced growth stimulation, cell aggregation, and membrane properties of ascites tumor cells in culture, Cancer Res., 44, 2668
  52. 10.1007/BF00788536 · DOI
  53. 10.1016/S0021-9258(17)45464-0 · DOI
  54. Schulz S., 1992, Mechanisms of cell growth inhibition and cell cycle arrest in human colonic adenocarcinoma cells by dehydroepiandrosterone: role of isoprenoid biosynthesis, Cancer Res., 52, 1372
  55. 10.1021/bi00548a032 · DOI
  56. 10.1073/pnas.80.3.692 · DOI
  57. 10.1016/0006-291X(82)91129-9 · DOI
  58. 10.1073/pnas.80.3.712 · DOI
  59. 10.1073/pnas.84.12.4012 · DOI
  60. Buttke T. M., 1980, Effect of sterol side chains on growth and membrane fatty acid composition of Saccharomyces cerevisiae, J. Bacteriol., 144, 124, 10.1128/jb.144.1.124-130.1980 · DOI
  61. 10.1016/S0021-9258(17)38374-6 · DOI
  62. Buttke T. M., 1992, Complete replacement of membrane cholesterol with 4,4′,14‐trimethyl sterols in a human T cell line defective in lanosterol demethylation, J. Biol. Chem., 267, 8819, 10.1016/S0021-9258(19)50353-2 · DOI

Cited by

Sorted by citations

Metadata

Authors
Martínez‐Botas, J., Suárez, Y., Ferruelo, A. J., Gómez‐Coronado, D., & Lasunció, M. A.
Affiliations
Servicio de Bioquímica‐Investigación Hospital Ramón y Cajal 28034 Madrid
Venue
The FASEB Journal
Publisher
Wiley
Published
1999-08
Volume
13
Issue
11
Pages
1359-1370
ISSN
  • 0892-6638
  • 1530-6860
Cited by
72
References
0
Language
en
Funders
Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FIS 94/0484)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review